Call for Patient and Caregiver Engagement
LCC is looking for lung cancer patients and their caregivers, in Canada or the US, who have received either:
- Cyramza (Ramucirumab) or
- Keytruda (Pembrolizumab) or
- Tagrisso (Osimertinib)
who are willing to share their experience (anonymously) with the drug.
Patient and caregiver experience is a key element in drug approvals and recommendations. We need your help!
Contact us at firstname.lastname@example.org